IMMUCOR AUTHORIZES STOCK REPURCHASE PROGRAM
IMMUCOR AUTHORIZES STOCK REPURCHASE PROGRAM NORCROSS, Ga., April 29 /PRNewswire/ -- Immucor, Inc.
(NASDAQ-NMS: BLUD), maker of blood bank reagent systems and related products, announced today it has authorized a program to repurchase up to 500,000 shares of its common stock in the open market.
The company currently has 7.8 million common shares outstanding. "Market conditions have provided us with an opportunity to enhance shareholder value by purchasing stock at attractive prices," said Edward L. Gallup, president of Immucor. Gallup also noted that the company is not committed to purchase any minimum number of shares, and the company may terminate the repurchase program at any time. Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used primarily by hospitals and blood banks in a number of tests performed to detect and identify certain properties of the cell and serum components of human blood prior to blood transfusion. -0- 4/29/92 /CONTACT: Richard J. Still, senior vice president - Finance of Immucor, 404-441-2051/ (BLUD) CO: Immucor, Inc. ST: Georgia IN: MTC SU: OFR
BN-EA -- AT012 -- 4370 04/29/92 12:18 EDT
|Printer friendly Cite/link Email Feedback|
|Date:||Apr 29, 1992|
|Previous Article:||MARITRANS PARTNERS L.P. ANNOUNCES RESULTS FOR QUARTER ENDED MARCH 31, 1992, QUARTERLY DISTRIBUTION, INTENTION TO CONVERT TO CORPORATE FORM|
|Next Article:||OCCIDENTAL PETROLEUM DECLARES DIVIDENDS|